V12 SENTINEL ENGINE · AI MARKET ANALYSIS
Mid
A
ABTAI Stock Diagnostic Report

Abbott launches "SimpleScreen" blood test to expand cancer screening

Abbott has raised expectations for growth in its diagnostics business by launching the 'SimpleScreen' blood test for expanded cancer screening.

View Source Article ↗
AI CATALYST SCORE65 / 100Score computed by Sentinel V12
REFERENCE PRICENot measuredReference entry price at analysis time
+
ANALYSIS HISTORY

ABT Analysis History (Last 30 Days)

Diagnosed AtTickerAI ScoreTier
2026-09-30 12:43:08ABT65MidView Report →
2026-09-23 15:03:43ABT42RowView Report →
2026-09-17 17:29:31ABT30RowView Report →
View Full History for ABT (Blueprint) →